ezogabine has been researched along with Tinnitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, GD; Salvi, R; Sheppard, AM | 1 |
| Duignan, KM; Edwards, S; Furuya, T; Kalappa, BI; Soh, H; Tzingounis, AV; Tzounopoulos, T | 1 |
2 other study(ies) available for ezogabine and Tinnitus
| Article | Year |
|---|---|
Potassium ion channel openers, Maxipost and Retigabine, protect against peripheral salicylate ototoxicity in rats.
Topics: Acoustic Stimulation; Animals; Carbamates; Cochlea; Cochlear Microphonic Potentials; Cytoprotection; Disease Models, Animal; Hearing Loss, Sensorineural; Indoles; KCNQ Potassium Channels; Large-Conductance Calcium-Activated Potassium Channels; Male; Otoacoustic Emissions, Spontaneous; Phenylenediamines; Potassium Channels; Rats, Sprague-Dawley; Sodium Salicylate; Tinnitus | 2015 |
Potent KCNQ2/3-specific channel activator suppresses in vivo epileptic activity and prevents the development of tinnitus.
Topics: Animals; Animals, Newborn; Anticonvulsants; Carbamates; Disease Models, Animal; Epilepsy; Evoked Potentials, Auditory, Brain Stem; Female; HEK293 Cells; Homeodomain Proteins; Humans; In Vitro Techniques; KCNQ Potassium Channels; KCNQ2 Potassium Channel; Male; Membrane Potentials; Mice; Mice, Inbred ICR; Mice, Knockout; Mutation; Phenylenediamines; Rats; Rats, Sprague-Dawley; Tinnitus; Transcription Factors | 2015 |